Methods for treating ocular neovascular diseases
OwnerDavid R. Guyerinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.
Claims20
A method for treating an ocular neovascular disease in a patient, said method comprising the steps of administering to said patient an effective amount of an agent that inhibits the development of ocular neovascularization, said agent being provided in a controlled release formulation comprising a biocompatible, biodegradable polymer selected from the group consisting of lactide polymers, lactide/glycolide copolymers, or polyoxyethylene-polyoxypropylene copolymers.
A method for treating age-related macular degeneration in a patient, said method comprising the steps of administering to said patient an effective amount of an anti-VEGF agent that inhibits the development of ocular neovascularization, said agent being provided in a controlled release formulation comprising a biocompatible, biodegradable polymer selected from the group consisting of lactide polymers, lactide/glycolide copolymers, or polyoxyethylene-polyoxypropylene copolymers.
Dependencies are inferred from the claim text.